Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007
Functional correlations between bronchial brush-biopsy composition and proteinases and its inhibitors in sputum in smokers and nonsmokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 578s Year: 2006
Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 520s Year: 2001
Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004
Glucocorticoid receptor alpha expression is reduced in lung parenchyma from COPD compared to normals and smokers subjects Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects Source: Eur Respir J, 56 (2) 2002378; 10.1183/13993003.02378-2020 Year: 2020
Differences in migrating neutrophils from patients with COPD compared with healthy smokers and non smokers and patients with alpha 1 antitrypsin deficiency Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Aminoguanidine inhibits bronchial NO production, but not diffusion or alveolar NO in patients with asthma, smokers and healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function Source: Annual Congress 2009 - Functional insights into COPD Year: 2009
Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Small airways disease evaluation in healthy smokers with normal spirometry values Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Expression of M3 receptors in bronchi from COPD compared to normals and smokers subjects Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Alveolar macrophage size is increased in COPD patients compared to controls Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Induced sputum microbiome in smoker and non-smoker COPD subjects and its association with lung function in Indian subjects Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017
Altered interaction of respiratory muscle activity, flow and lung volume in infants with chronic lung disease compared to healthy controls Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008